OneMedNet announced an $11.5 million agreement to provide its iRWD™ imaging data platform for training a foundational AI model. This significant contract validates the company's technology and provides a substantial revenue boost, leading to a strong after-hours stock rally.
OneMedNet (ONMD) secured an $11.5 million agreement to supply its regulatory-grade iRWD™ imaging data platform for training a foundational AI model. This deal is highly significant as it represents a substantial revenue injection for a company with a market capitalization of only $40.11 million, validating its technology and market position in the rapidly growing AI healthcare data space. The immediate delivery of de-identified medical imaging and clinical reports suggests a quick revenue recognition. This is a strong short-term positive catalyst, driving a 33% after-hours rally, and could signal further growth opportunities as AI model development continues to demand high-quality real-world data. The key opportunity for traders is the potential for continued upward momentum and re-evaluation of the company's valuation given this new contract and its strategic implications.